2015年12月6日星期日
How to buy Artesunate,Artesunate sales
Product name:Artesunate
CAS: 88495-63-0
Molecular Formula:C19H28O8
Formula Weight: 384.42
Would like to ask specific details, please click here Email: sales@acridine-raw-material.com
Description:
Artesunate (INN) is part of the artemisinin group of drugs that treat malaria. It is a semi-synthetic derivative of artemisinin that is water-soluble and may therefore be given by injection. It is sometimes abbreviated AS.
Artesunate is used primarily as treatment for malaria; but it has also been shown to be >90% efficacious at reducing egg production in Schistosoma haematobium infection
From:http://www.acridine-raw-material.com/products/Artesunate/
Japanese vaccine providers undocumented pharmaceuticals for 40 years was exposed Japan has accounted for three percent of the influenza vaccine market
Japan accounted for influenza vaccine market up to 30 percent of "Chemistry and the Institute of serum therapy" (of the Blood Institute), was discovered over 40 years ago from the use of non-government-approved way to produce blood products and vaccines, including for infants of Four vaccine. Company executives not only withholding information, and more deliberate forgery fraud regulatory agencies for many years. Makoto Miyamoto Blood Institute, chairman of the second nine directors today announced collective resignation or demotion, and apologize to the public.
Pfizer's acquisition of El build, investors are not optimistic about?
Al built on Zhou Huirui finally reached a merger agreement is expected to become the world's largest pharmaceutical companies. It
is reported that the proposed merger will be subject to the approval of
both the United States and European regulators will ultimately complete
the merger in 2016. Supposedly giant's share price will likely skyrocket to win the favor of investors.
However, recent global financial news CNBC host Jim Cramer, but that the situation is not as clear as expected. In addition to Jim Cramer, Nomura Securities analyst Shibani Malhotra also said that despite the merger agreement reached after, Al-built stock prices rebounded, but investors are still difficult to recognize the long-term potential value of this transaction brings.
Al build than the current stock price of $ 370.53 15.9% expected lower share value that the company reached a merger agreement substantially undervalued by investors.
So how the actual situation? What are the main points to be ignored investors?
First, the new company's headquarters will be based in Ireland, which is also the maximum income tax inversion. This will bring to El build a more flexible fiscal, while resulting in increased dividends, and this is currently ignored by investors. Al dividend currently built not more than 52 US dollars, while it is estimated that Pfizer's dividend will reach $ 52.53.
Followed by Pfizer expanding global map. Pfizer's global market is expanding, while Al Jian said that after the merger will help Pfizer to penetrate into China and Japan and other major markets. Built for Al, the ophthalmic pharmaceutical market in Asia and gastrointestinal disease drug market in Europe will be a very important opportunity.
In addition, Al build current executives - such as CEO Brent Saunders will serve as the new company COO, and current chairman Paul Bisaro will also held senior positions in the new company. This will effectively strengthen the new company's management and promotion.
Al build long continue to uphold the "growth-oriented pharmaceutical" model and philosophy, coupled with the combined use of Pfizer larger platform, its development will be more flourishing.
However, recent global financial news CNBC host Jim Cramer, but that the situation is not as clear as expected. In addition to Jim Cramer, Nomura Securities analyst Shibani Malhotra also said that despite the merger agreement reached after, Al-built stock prices rebounded, but investors are still difficult to recognize the long-term potential value of this transaction brings.
Al build than the current stock price of $ 370.53 15.9% expected lower share value that the company reached a merger agreement substantially undervalued by investors.
So how the actual situation? What are the main points to be ignored investors?
First, the new company's headquarters will be based in Ireland, which is also the maximum income tax inversion. This will bring to El build a more flexible fiscal, while resulting in increased dividends, and this is currently ignored by investors. Al dividend currently built not more than 52 US dollars, while it is estimated that Pfizer's dividend will reach $ 52.53.
Followed by Pfizer expanding global map. Pfizer's global market is expanding, while Al Jian said that after the merger will help Pfizer to penetrate into China and Japan and other major markets. Built for Al, the ophthalmic pharmaceutical market in Asia and gastrointestinal disease drug market in Europe will be a very important opportunity.
In addition, Al build current executives - such as CEO Brent Saunders will serve as the new company COO, and current chairman Paul Bisaro will also held senior positions in the new company. This will effectively strengthen the new company's management and promotion.
Al build long continue to uphold the "growth-oriented pharmaceutical" model and philosophy, coupled with the combined use of Pfizer larger platform, its development will be more flourishing.
Metformin or did not improve over the adolescent patients with severe type 1 diabetes
A
study published in the international journal JAMA research papers,
scientists from the Jaeb Health Research Center conducted a clinical
trial, including the risk of type 1 diabetes in overweight and obese
adolescents study found that metformin added to insulin in perhaps six months later and the situation does not improve glycemic control in patients.
For adolescents with type 1 diabetes, overweight or obese can potentially lead to severe metabolic disorders, especially in the period of adolescence; in adolescents in the study, a high dose of insulin can overcome obesity, insulin resistance, at the same time also trigger puberty individual blood glucose control difficult, but the future lead to weight gain individual; and Metformin is an oral hypoglycemic agents, commonly used to treat type 2 diabetes mellitus; metformin on previous studies assessed adolescents with type 1 diabetes blood glucose control , but did not get the results uncertain.
The researchers randomly assigned Dr. Kellee M. Miller in the article of 140 aged 12-19 years old adolescents with type 1 diabetes with metformin or placebo treatment period of 6 months, individuals with diabetes is at least seven years, and receiving metformin The dose of 2000mg / d or more, the trial while 26 pediatric endocrinology diagnostics; researchers found that although 13 weeks of metformin group of individuals body glycated hemoglobin
For adolescents with type 1 diabetes, overweight or obese can potentially lead to severe metabolic disorders, especially in the period of adolescence; in adolescents in the study, a high dose of insulin can overcome obesity, insulin resistance, at the same time also trigger puberty individual blood glucose control difficult, but the future lead to weight gain individual; and Metformin is an oral hypoglycemic agents, commonly used to treat type 2 diabetes mellitus; metformin on previous studies assessed adolescents with type 1 diabetes blood glucose control , but did not get the results uncertain.
The researchers randomly assigned Dr. Kellee M. Miller in the article of 140 aged 12-19 years old adolescents with type 1 diabetes with metformin or placebo treatment period of 6 months, individuals with diabetes is at least seven years, and receiving metformin The dose of 2000mg / d or more, the trial while 26 pediatric endocrinology diagnostics; researchers found that although 13 weeks of metformin group of individuals body glycated hemoglobin
2015年12月3日星期四
Human gene editing technology cited strong debate
Entitled "CRISPR-Cas9" gene editing technology can quickly and
efficiently modify the human eggs, sperm and embryos, it is also able to
change the unborn baby's DNA.
Loyola University Chicago (Loyola University) College dean of Catholic moral theology Shearer · Hakor (Hille Haker) at the meeting opposed the gene editing technology, and support for changes in human germ cells involve the implementation of a scientific study period a two-year international ban.
In Hakor opinion, once made modification of human germ cells, and that this is likely to be passed on to offspring. She said that doing so would violate the freedom of those unborn babies. Because these babies have no chance to express his (her) willingness to agree to change their genetic code.
And Hakor different, University of Manchester (University of Manchester) bioethics professor John Harris strongly supports the "CRISPR-Cas9" gene editing technology.
"We are faced with an inescapable moral responsibility: to continue scientific research until we reach a point of rational choice so far but we have not yet reached this point, in my opinion, to suspend the technology is a wrong choice. , the study of this technique is necessary. "Harris said.
Loyola University Chicago (Loyola University) College dean of Catholic moral theology Shearer · Hakor (Hille Haker) at the meeting opposed the gene editing technology, and support for changes in human germ cells involve the implementation of a scientific study period a two-year international ban.
In Hakor opinion, once made modification of human germ cells, and that this is likely to be passed on to offspring. She said that doing so would violate the freedom of those unborn babies. Because these babies have no chance to express his (her) willingness to agree to change their genetic code.
And Hakor different, University of Manchester (University of Manchester) bioethics professor John Harris strongly supports the "CRISPR-Cas9" gene editing technology.
"We are faced with an inescapable moral responsibility: to continue scientific research until we reach a point of rational choice so far but we have not yet reached this point, in my opinion, to suspend the technology is a wrong choice. , the study of this technique is necessary. "Harris said.
Medroxyprogesterone Acetate for sales online
Product name:Medroxyprogesterone Acetate
CAS: 71-58-9
Molecular Formula: C24H34O4
Molecular Weight: 386.52
Would like to ask specific details, please click here Email:sales@chemicalspharm.com
Product description:1. Provera is mainly used for dysmenorrhea, functional sex amenorrhoea, functional uterine bleeding, threatened abortion, habitual abortion or endometriosis, treatment of advanced breast cancer, endometrial adenocarcinoma, and kidney. 2. Large doses can be used as a long-term contraceptive injections.
Pharmaceutical products of Helicide,how to buy Helicide
Product name:Helicide
CAS: 80154-34-3
Molecular Formula: C13H16O7
Molecular Weight: 284.26
Product description:Its chemical structure and gastrodia glycosides (gastrodin, to hydroxyl methyl benzene - O - beta - D - pyran glycosidase) similar, pharmacology and clinical studies have shown that tofu fruit glycosides in the central nervous system has a similar role as gastrodia glycosides, but its sedative and sleeping, strong analgesic effect than gastrodia glycosides, neurosis to treatment curative effect and no rebound sex insomnia and produce the side effects, such as drug dependence has good clinical value. Products made of the god failure shenshuaiguo tablet has been used in clinical.
Would like to ask specific details, please click here Email:sales@chemicalspharm.com
订阅:
博文 (Atom)